Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease

被引:53
作者
Carter, Jodi M. [1 ]
Hoskin, Tanya L. [2 ]
Pena, M. Alvaro [3 ]
Brahmbhatt, Rushin [3 ]
Winham, Stacey J. [2 ]
Frost, Marlene H. [4 ]
Stallings-Mann, Melody [5 ]
Radisky, Derek C. [5 ]
Knutson, Keith L. [6 ]
Visscher, Daniel W. [1 ]
Degnim, Amy C. [3 ]
机构
[1] Mayo Clin, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Surg, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Med Oncol, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA
[6] Mayo Clin, Dept Immunol, Jacksonville, FL 32224 USA
关键词
ELEVATED AROMATASE EXPRESSION; ADIPOSE-TISSUE; ADIPOCYTE DEATH; INFLAMMATION; OBESITY; WOMEN;
D O I
10.1158/1940-6207.CAPR-17-0245
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In breast adipose tissue, macrophages that encircle damaged adipocytes form "crown-like structures of breast" (CLS-B). Although CLS-B have been associated with breast cancer, their role in benign breast disease (BBD) and early carcinogenesis is not understood. We evaluated breast biopsies from three age-matched groups (n = 86 each, mean age 55 years), including normal tissue donors of the Susan G. Komen for the Cure Tissue Bank (KTB), and subjects in the Mayo Clinic Benign Breast Disease Cohort who developed cancer (BBD cases) or did not develop cancer (BBD controls, median follow-up 14 years). Biopsies were classified into histologic categories, and CD68-immunostained tissue sections were evaluated for the frequency and density of CLS-B. Our data demonstrate that CLS-B are associated with BBD: CLS-B-positive samples were significantly less frequent among KTB biopsies (3/86, 3.5%) than BBD controls (16/86 = 18.6%, P = 0.01) and BBD cases (21/86 = 24%, P = 0.002). CLS-B were strongly associated with body mass index (BMI); BMI < 25: 7% CLS-B positive, BMI 25-29: 13%, and BMI >= 30: 29% (P = 0.0005). Among BBD biopsies, a high CLS-B count [> 5 CLS-B/sample: 10.5% (BBD cases) vs 4.7% (BBD controls), P = 0.007] conferred a breast cancer OR of 6.8 (95% CI, 1.4-32.4), P = 0.02, after adjusting for adipose tissue area (cm 2), histologic impression, and BMI. As high CLS-B densities are independently associated with an increased breast cancer risk, they may be a promising histologic marker of breast cancer risk in BBD. (C) 2017 AACR.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 31 条
  • [1] Aromatase, breast cancer and obesity: a complex interaction
    Bulun, Serdar E.
    Chen, Dong
    Moy, Irene
    Brooks, David C.
    Zhao, Hong
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2012, 23 (02) : 83 - 89
  • [2] Prostaglandin E2 induces breast cancer-related aromatase promoters via activation of p38 and c-jun NH2-Terminal kinase in adipose fibroblasts
    Chen, Dong
    Reierstad, Scott
    Lin, Zhihong
    Lu, Meiling
    Brooks, Chris
    Li, Newton
    Innes, Jon
    Bulun, Serdar E.
    [J]. CANCER RESEARCH, 2007, 67 (18) : 8914 - 8922
  • [3] Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
    Cinti, S
    Mitchell, G
    Barbatelli, G
    Murano, I
    Ceresi, E
    Faloia, E
    Wang, SP
    Fortier, M
    Greenberg, AS
    Obin, MS
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (11) : 2347 - 2355
  • [4] Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development
    Degnim, Amy C.
    Hoskin, Tanya L.
    Arshad, Muhammad
    Frost, Marlene H.
    Winham, Stacey J.
    Brahmbhatt, Rushin A.
    Pena, Alvaro
    Carter, Jodi M.
    Stallings-Mann, Melody L.
    Murphy, Linda M.
    Miller, Erin E.
    Denison, Lori A.
    Vachon, Celine M.
    Knutson, Keith L.
    Radisky, Derek C.
    Visscher, Daniel W.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3945 - 3952
  • [5] Immune cell quantitation in normal breast tissue lobules with and without lobulitis
    Degnim, Amy C.
    Brahmbhatt, Rushin D.
    Radisky, Derek C.
    Hoskin, Tanya L.
    Stallings-Mann, Melody
    Laudenschlager, Mark
    Mansfield, Aaron
    Frost, Marlene H.
    Murphy, Linda
    Knutson, Keith
    Visscher, Daniel W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (03) : 539 - 549
  • [6] Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues
    Degnim, Amy C.
    Visscher, Daniel W.
    Hoskin, Tanya L.
    Frost, Marlene H.
    Vierkant, Robert A.
    Vachon, Celine M.
    Pankratz, V. Shane
    Radisky, Derek C.
    Hartmann, Lynn C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (01) : 169 - 177
  • [7] uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
    Duffy, Michael J.
    McGowan, Patricia M.
    Harbeck, Nadia
    Thomssen, Christoph
    Schmitt, Manfred
    [J]. BREAST CANCER RESEARCH, 2014, 16 (04):
  • [8] RISK-FACTORS FOR BREAST-CANCER IN WOMEN WITH PROLIFERATIVE BREAST DISEASE
    DUPONT, WD
    PAGE, DL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) : 146 - 151
  • [9] Benign breast disease and the risk of breast cancer
    Hartmann, LC
    Sellers, TA
    Frost, MH
    Lingle, WL
    Degnim, AC
    Ghosh, K
    Vierkant, RA
    Maloney, SD
    Pankratz, VS
    Hillman, DW
    Suman, VJ
    Johnson, J
    Blake, C
    Tlsty, T
    Vachon, CM
    Melton, LJ
    Visscher, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (03) : 229 - 237
  • [10] Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study
    Hartmann, Lynn C.
    Radisky, Derek C.
    Frost, Marlene H.
    Santen, Richard J.
    Vierkant, Robert A.
    Benetti, Lorelle L.
    Tarabishy, Yaman
    Ghosh, Karthik
    Visscher, Daniel W.
    Degnim, Amy C.
    [J]. CANCER PREVENTION RESEARCH, 2014, 7 (02) : 211 - 217